U
TGX

UBS’s THERAGENICS CORP TGX Stock Holding History

UBS’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-20,364
Closed -$44K – 11341
2013
Q3 		$44K Buy
20,364
+19,364
+1,936% +$41.3K ﹤0.01% 7049
2013
Q2 		$2K Buy
+1,000
New +$1.79K ﹤0.01% 9953

UBS's TGX Position: Q4 2013 in Review

UBS sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 20,364 shares — an estimated $44K sold.

UBS first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $44K in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • UBS reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • UBS sold 20,364 THERAGENICS CORP shares in Q4 2013, an estimated $44K.
  • UBS first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • UBS's THERAGENICS CORP position peaked at $44K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.